 TIGR, what do you think? I'm not familiar with TIGR, but thank you for the pick. Jessica says, looks like the Afria Tillray merger is going to put till rate in 60. Hey, Kiran, Kiran, can you pick? Perfect. How you doing? I'm doing well, doing well, how are you? I'm doing great, we're ready live. We got 142 people watching. Wow, that's a big number. Yeah, and I'm excited to speak with you. It's been a while and you guys have been with me. And since the last time we talked, the stock has doubled. So congratulations. Wow, yeah, that's quite an achievement, quite an achievement. You know, a lot of people were really nervous about, you know, when we put in the reverse splits. And what I explained to people at the time is look, we're not doing it to what I call, you know, make the bids disappear in trader speak, but we were doing it just, you know, what we're hearing now, you know, Schumer saying, you know, full de-scheduling, you know, it looks like things are moving really fast. And, you know, to get on NASDAQ, you know, people were being cynical and saying, oh, you don't have the market cap. Now we do have the market cap. And, you know, those reverse splits will really to get the stock price up to where it needed to be, where it's, you know, somewhere between, you know, I'm not a NASDAQ expert, but somewhere between, you know, three to $5 US in case we had to do it, you know, because I think it's, you know, and it's just a gut feeling. I think banking reform is going to go through. And I do think that NASDAQ will open up to US plant touching companies within the next two years. Wow, that's huge. Is that why the stock market for cannabis stocks is just going nuts today? Was there any news or is there any specific reason? Because you know, I, you know, it's, it's, you know, I don't, you know, I, we're really sort of laser focused on our two markets in the US, which are California and Oregon. And, you know, both those markets, even despite what I would call draconian lockdowns, which are now loosening in Los Angeles and in San Francisco, there just seems to be a general shift of people when they're sitting at home, stewing, wanting to smoke a joint rather than drink a beer, you know, and you're just seeing those statistics. And, you know, in marijuana in general is a medicine while, you know, alcohol, you know, looking at it from a recreational point of view is really a depressant. It's a, you know, causes liver cirrhosis. It causes all sorts of problems. So, you know, I'm glad to see that. Now, you know, eventually psilocybin's on the horizon. Yes. And that's, I mean, and that's going to be, you know, another big component. And we're really seeing some great liberalization. And I'm sure Rand Paul Sr., Rand Paul Jr., the Republican Senator from Kentucky's father is probably smiling, you know, really smiling, you know, and to say that I'm sure Rand Paul Jr. himself is quite supportive of everything that's going on. Are you guys getting into psilocybin? Are you guys getting into psychedelics? Well, yeah, yeah, definitely. We're definitely going to do that. And that is, all right. So, Oregon is going to be the first market for medical use of psilocybin, right? It's the first market that's legalized. The laws are being promulgated this year and by next year it's going to be open, you know, we're going to, clinics will start opening. Our roots are in manufacturing. And because our roots are in manufacturing, we're going to be there in their manufacturing. And we announced a, we announced the joint venture, we're going to be formalizing into a company and everything with Red Light Holland, CSC, TRIP, great company. I mean, Todd's a great operator. And as usual, like what we do is we look for new technologies around mushrooms. And the thing about psilocybin, which is interesting not to go too deep, is that it's the unpredictability of dosing. So, you know, the old school thing is, you know, what do they say? You know, you put mushrooms in the dark and you feed them a lot of shit. You know, that's always been the saying, but the problem is there's a variability of the natural molecule. And recently I've been speaking to people about who are going to start using bioreactors with antibiotics to, you know, like antibiotics are to start, you know, manufacturing the natural molecule as you would manufacture on antibiotics and bioreactors, which I think is pretty cool. But then an article was recently published in Nature Magazine talking about using some of the, you know, RNA technology that's being used with the vaccines to actually start delivering, to replicating natural mushrooms that are completely predictable and docible. So it's really, there really it's a dosability thing. But in the interim. Yes, they're so busy, man. Every time I talk to you, you got something new. And I'm like reading news, like record revenues and new agreements with two additional dispensaries in LA. Like you're gotta be one of the busiest guys in the sector, man. Non-stop. We are busy, but you know, everyone is, everyone right now is pretty much, you know, cashed up. And so the issue right now is really, to really keep sort of focus, like when we speak about psilocybin, we're talking about Oregon. That's our market, right? When we talk about new dispensaries, we're talking about California. That's our market. You're not seeing us and you're seeing us already saying to ourselves, look, we were probably divesting out of Nevada because we got our hands full in California and that's been a theme in Oregon. And so US-wise, we're really focused on the states we're in, right? If there are opportunities to maybe JB or do other stuff in other states, we may do it. But you know, they're playing rides away, right? And you know, Arizona, you can see, you know, Kira and Harvest are pretty well entrenched there. You know, Washington, I'd love to do Washington, but you know, there's the residency requirement. I personally am a Washington resident. Yesterday I was visiting with Ryan, you know, the owner of Habahart who sold his dispensaries to Harvest that inevitably went into high times, but he's still the dominant player in Washington state. You know, I know that they've been trying to lobby there and that's the second largest state, I think the third largest state in the country. They've been really trying to lobby there to not to loosen that residency requirement which will enable us public companies to come in, right? But I like that sort of continuity of geography because it's easy to manage and it's easy to move people around. When if you start, you know, and I don't know how these MSOs do it. I honestly don't know, you know, hats off to ColumbiaCare, to GTI, to Kira. I just don't know how they manage such huge portfolios. Granted, what? We're probably today a $150 million company and they're what, two, three billion dollar companies. So, you know, there must be a way, but, you know, I find it definitely in, you know, in our minds where they're really two, we really have two, we really actually have three businesses when you look at it. So we have, you know, what we call our manufacturing of dispensary product with distribution to dispensaries in Oregon, where, you know, ourselves in terms of units sold and dollars sold for BDS data is number one, number two is Wild, which is a tremendous company, but they're only edibles. I mean, hats off to Aaron and what he's done. It's just a remarkable business. And then in California, we're actually looking at it a little bit differently and we're looking at it that, you know, what we've learned in Oregon is the middle stuff, the manufacturing and the distribution really is what we call cost of capital businesses and cultivation and dispensing is where you really make a lot of money. So in California, you know, with Barracks, where there's gonna be some big news come and hopefully soon, that is, you know, I can't say it's the largest outdoor grow in the state because that's pro farms, but I can tell you it's the second largest licensed outdoor grow that I know of in the state, but we're in the Emerald Triangle. I can't tell you that it's the largest greenhouse operation in the state, because that's glasshouse farms, but I can tell you that it's the second largest greenhouse operation in the state if we get 20 acres up. And, but I can tell you combined, I don't know of a single cultivation site that's anywhere close to that, right? Wow. And so once that's, once that going, and you know, with Jed and Joe and they own a big piece of connected and the genetics are, you know, you know, that alien lab, some of that genetics is coming out of, you know, the connected, let's call it the connected family tree. And you look at the three dispensaries we have and you look at the locations of those dispensaries, if you know LA, I would argue that that's one of the best portfolios in the city of Los Angeles. You're only allowed three. And now we're aggressively pursuing, you know, West Hollywood, we're aggressively pursuing dispensaries in other places, you know, we have our edibles now, we got our vapes, we got flower shop launching with some really unique products. And, you know, I spent, I think it was, was it last week or the week before I can't remember they start to meld. I spent a whole day with a GEZ in his house and his new girlfriend, Ashley Monroe. And I saw the pictures. I was like, oh my goodness, this is so cool. You're hanging out with GEZ. Yeah, yeah, yeah. And I was, you know, I'm not used to, I'm not used to, how do you say it? I'm not used to these like photo shoots, like he is and stuff. So, you know, he gave me a nice, nice little, little shot of Henedora 25 Blanco. Calm you down a little bit. Yeah, smoked a little nice indoor and then I learned the ropes a little bit. But no, what's really cool about the Franklin location that we announced, it's, it is literally a mile from his house. His home is right below the Hollywood Hills and, and he's active, you know, it's not sort of like, okay, sign a deal with Drake and is he gonna show up in your stores? No, GEZ really active due to his mother and due to, you know, just being an Oakland guy. It's, you know, he's a real partner. And I really, you know, sort of feel that vibe. And it's, you know, it's a first name basis type partnership. You know, it's not through 10 agents and everything, you know. That's awesome. Yeah, that is so exciting. That's one of the biggest artists in the world guys. GEZ is one of the biggest artists in the world working with Halo Collective. Let's talk about Halo Collective. Today I look at the name and it's no longer Halo Labs, Halo Collective. Why the name change? Because we started as a lab company and a chicken coop but now we have dispensaries, we have cultivation. I, you know, arguably we're the, we run the most trucks now in Oregon. So we're a distributor, you know, we're a pre-roller. I mean, we do, you know, we do almost everything except right now for the hash and the live rosin but that's coming soon. So we're really now, we're really not even a, we're not really an MSO. We all only operate in two states but we operate in multiple countries. So, you know, I don't know, what do you call us? CSO, no, multi-country operator, MCO. But a global producer, you're a global producer, right? So, you know, and we like the name Collective because we sort of like the throwback to, you know, the old school California collective sort of model, right? Where we're all sort of, you know, Louisa, especially, you know, with her social empowerment stuff and everything is, you know, we want to, you know, a lot of what we're doing overseas is we want to collectively give back, right? Especially in, especially in Lesudu. I mean, you know, she's a big prom legator of, you know, the under whatever she calls them. I kind of forgot the name, but there's a name for it but the under privilege, especially, you know, women in villages, you know, and Andreas was, you know, talking, it was really funny. He was telling me, you know, stories about how people, you know, walk miles to come to work, right? You know, from, you know, from the local villages around to, you know, cultivate. I mean, we're growing. I mean, we are growing. We have tested marijuana in Lesudu. It's not, it's not a soccer field in Columbia. It's a real, it's a real grow. And, you know, and then I said, Andreas, I said, you know, that sounds really bad that people are walking miles to go to work. And he said, Kieran, there's COVID. We can't put a whole bunch of people on a bus. Yes. I go, that's a good point, you know. That's a good point. I mean, we got a point, right? You guys have been doing so much, like you've also just been reporting record revenue growth. Can you talk a little bit about that and how your bottom line is looking right now? Well, well, the, right now, I can't talk about how our bottom line is looking, especially, you know, with earnings and everything coming out. All I can tell you is that what we've said to, what we've said in our releases is that revenues are growing, gross margins are growing. Right? But we've had to bring on, you know, some new executives. We brought on Joshua Haddix from Moxie, right? He was the VP of operations there and he's doing a dynamite job. Moxie is probably the father of the concentrate business. I mean, Jordan is probably the godfather of the concentrate business. Wow. That's a good idea. And so to bring him on was a big, was a great hire. Because remember, Andreas moved overseas. He's living in Lesudu right now. And then we brought on Dustin Jessup, who's running, you know, all our sales in California and Oregon. And we picked him up during the Winbury acquisition. And that Winbury acquisition, you know, overnight doubled us. But when we talk about record revenue growth, and if you look at our charts, you know, we're honest about it. So you see Winbury in there, even though it's pro-forma. It's not like, oh, we doubled revenue, right? And people are like, oh, well, that, you know, that isn't organic. I go, yes, that's true. We know, but even organically, we're growing at 20 to 30%. I mean, you know, that's what you do acquisitions for, right? To, you know- I mean, if you're growing organically, you're not going to have explosive growth, right? If you grow acquisition, that's how you grow. That's how you have explosive growth. When you do both, that's when you have a great business. And that's what we're thriving towards, you know? And, you know, we're, it's just, you know, all hands on deck, you know, some act, you know, it's just a question right now, really, from my perspective in the U.S. of managing growth. But we should flip to international, because international's, international, whereas COVID has benefited the U.S. internationally, it's been, it's been tough, right? It's been tough. I mean, these lockdowns internationally, I mean, in the UK with this new variant and everything, it's been, you know, it's been tough, right? So where the U.S. is sort of spinning off cash, international, even though I think new cannabis ventures and everyone says it's the future, you know, we're struggling with basic stuff like steel for fences, because there's no steel in South Africa to bring into Lesotho, right? But we still keep going, right? We still work within, you know, we have permission from the local authorities and the police to operate. We're operating, we're expanding. We're looking at, you know, getting, finally getting those one-hector, you know, greenhouses up. We got our strains propagating. I think we're on our third harvest there, you know. And there's a saying I have about Halo that I've been thinking about a lot recently and it's called intrinsic value. And so I think Halo really trades on, when I look at it being a former banker, you know, having worked at Maryland, paid my dues at Wharton for a couple of years. I don't think our international assets are getting the intrinsic value they really deserve. So we're, as a board, we've been looking at, you know, what do we do to, you know, we have some pretty good international assets and we have a very good partner with MedCan and Malta. And what do we do to sort of put those in a seed to sail line, right? Because we have, you know, if you look at it, conceptually with our partner MedCan, you know, we have a massive grow in Lesudu. You know, I could argue like other companies have and say it's the largest in the grow and largest potential grow in the world, but it probably isn't. It's probably one of the larger, you know, grows and, you know, right in the world or the potential to be. But you have that and then you have what I call some really good genetics there, like good, you know, it's sort of like probably what happened with Bordeaux and Napa, you know, when you got, when you had all those great strains that came from Bordeaux to Napa in the day, right? So we've taken now, let's call it the California bougie strains and all of that and sent them off to Lesudu, sort of like they have Stelenbosch wine in South Africa. So we're gonna, you know, it's gonna be defined as its own area over the next couple of years. Then through MedCan, if we can ever get through these COVID lockdowns, right? Then we can export our GACP product there. They have a GMP facility. They can make it into oil there. I mean, we have a great partner there. And then inevitably we can distribute it from there throughout the world, right? And a lot of people say, well, why aren't you making oil in Africa? I'm saying, listen, you know, to be quite frank, it's hard enough to grow in Africa right now and it's hard enough to find steel. You know, let's make the oil in Europe. And, you know, because right now when you look at this international market really, it's sort of where Canada was maybe five years ago, right? So you got flour, right? And then you got, you know, tinctures, olive oil based tinctures, right? So and the tinctures are starting to grow, right? Obviously, you know, probably in the black market you got everything, but the white market, the medicinal markets really those two products and it's just gonna grow from there. And then, you know, now we've had Brexit. So Canmar in my mind becomes a little more valuable in and of itself because you're not, you know, if you have MedCan as a partner who can do Europe and the rest of the world, Canmar that can do the UK. And I'm not, listen, I'm not comparing my business or our business in any way to GW Pharma, but I mean, that's $7 billion price tag. Wow, wow, that was stunning, huh man? But they're like, I mean, they're down in San Diego and I've had a drink with one or two of them, but man, I mean, that was, that's just, it just shows you what the potential is, you know? It's the potential of genetics, potential of, you know, just the potential of some of these medicines and what you can do really, you know, in the future, right? And I think you're gonna see a lot of that in psilocybin because psilocybin needs precision, it needs modulation, it needs dosing, it's, psilocybin's really pharma in the end of the day, right? Where marijuana is marijuana, it's an herb, something we smoke all the time or psilocybin, you know, you take one micro dose and you feel nothing, you take your second micro dose and you're flying because the amount of psilocybin in that, you know, in that capsule is, you know, even though it's the same mushroom, right? Grinding just the amount of psilocybin in that part of that head of that mushroom, right? Was substantially more. First people have a bunch of questions, huh? I'm sure you're probably getting- Well, I mean, there's a lot of questions coming, there's a lot of, there's a lot of excitement, there's a lot of interest, but you've kind of talked about everything and you've kind of answered most of the questions. I don't really see any new questions coming right now. If there was one thing you'd wanna let investors know about Halo Collective now moving forward in 2021, what would it be? So in, remember how in 2020, I kept telling everyone balance sheet, right? Yes. And, you know, we had some positive EBITDA, in the fourth quarter, we may have some positive EBITDA, definitely really improved gross margins, right? With the WinBerry numbers coming in in January, this Q1 is, you know, I'm expecting it to be a really good first quarter, for a really good first quarter, right? Really strong, strong first quarter, I mean, in terms of all metrics. And as you can see, we consistently put out our numbers, I owe everyone a BDS release in the next day or two, good, bad or wherever it's at, you know, I report where we stand in the BDS data every month, so December will be coming out in the next day or two. So what I wanna say is that we're shifting from balance sheet, now that our balance sheet is really strong, to income statement, right? So now you're gonna start to see, you know, and it's, and I'll tell you, it's damn hard with 280E in the US, the tax to get PAT, profit after tax, right? But, you know, I'm really gonna strive by Q2, to go into PBT, which is profit before tax. And that's really what the goal is, is to sort of shift the mentality now, that, you know, we survived the vape crisis and we survived, you know, the markets being down, now the markets are have overheated, you know, we did a bot deal in a day or two. I was really nervous about that, right? When we did that bot deal with eight capital and then, you know, Canacord, God bless him, stepped in and helped out and PI, you know, Blake Corbett, he was there and, you know, we did that deal overnight and I was really nervous and I'll tell you why I was really nervous. And again, putting on my sort of trader hat, we sold a unit at nine cents. So basically you got a, you got one share at nine cents and then you got a full warrant at 12 cents. So what would a typical, and this was all sold mostly to institutions. So what's an institution gonna do? They're gonna sell the share at nine cents, right? And they're gonna keep the warrant at 12, right? And they get the warrant at 12 for nothing. The warrant's gonna list by Friday. I'm listing it as fast as I can so it causes no overhang to the stock, right? And so I was really, if you saw the stock, it was trading like massive volume at between nine and 10. And I was really nervous about it breaking out because all of a sudden you have eight million, let's say the full shoes exercise, you have 10 million of nine cent units where everyone wants to blow out. You know, if anyone is smart and they're a trader, they're gonna sell their stock. If they could sell their stock at 10 cents, get a warrant for free at 12 cents. I mean, that's the deal of a century. We list the warrant, I may be speaking Swahili to some people, you blackshells out the warrant, the warrant's gonna come out at three cents with the stock at 11 cents. So all of a sudden, then you can sell the warrant, let's say at three to four cents. All of a sudden in a week, you spent nine cents, you made 14 cents, right? So if you're an institution, you gotta, I mean, the IRR is off the charts, right? So I was a little nervous about that and I'm happy that, you know, that we've sort of what I call eight through that, right? So I don't, what I'm seeing is what I'm saying is the warrant being listed, the 12 cent warrant being listed just from a chart perspective, right? Obviously we're locked up, you know, because of the offering and because of us coming so close to the numbers, you know, numbers reporting. I was happy to see the stock today break out to 11, right? Because I think now that sort of overhang from that bought deal is out of the way. Now, I don't see what I'm seeing, I don't see any headwind, right? When I look at the stock, I'm not seeing that headwind that I was nervous about three or four days ago. So I'm kind of relieved. Well, the timing is good too, because like the whole cannabis sector is exploding. So the timing was perfect because you're not the only stock that's done well, the entire cannabis sector is doing well. And hopefully it continues to go in this direction. And then we'll see Halo go even higher. Yeah, but, you know, but I think, you know, and I try not to compare myself to or compare the company to others, but I would say that as a board, I think we're pleased that, you know, we had a stock that was trading at five cents. Let's say, well, maybe 30 days ago, we got a bought deal done at nine cents with a full warrant at 12, and we got a stock at 11, three days after the deal closes and everyone has their stock in their hands. And I think today we traded in the US, I don't know, maybe I would guess eight to 10 million shares, HKANF, you can look. And then we traded in Germany, I think 30 million shares. Wow. And on the NEO, I have no idea, I could look it up, maybe 10 to 12 million shares, right? Maybe more. You know, but yeah, in terms of, that's the other thing that's really, you know, that's really good about, you know, I think our stock is that I was looking at a stoic report. And in terms of number of shares, granted our stock was at five cents, but it's still at 11 cents. In terms of number of shares traded per day on a global basis, we're the number one, or we were the number one traded cannabis stock. And we're in the top 15 or 20 worldwide, just in terms of dollar volume on a daily basis or something like that. Wow, that's impressive. And that was an independent report. Yeah, so I mean, the stock trades and, you know, we put out news, whether it's good or bad and, you know, and, you know, try to just, just keep trying to grow the company, you know, and get some sleep in between. One thing I've always said to everyone, I said, even when the stock was at five cents, I said, regardless of the stock, I love the business. I've always loved the business, regardless of the stock. Now, for those of people that got in at five cents and got a chance to double their money, now not only are you buying a business that I think is very undervalued, but now you're getting a chance to make some upside on the stock. It's one of those situations where, you know, I've been around this industry for so long and what's more important, a high share price or stock that's liquid. The reality is the stock that's liquid. I mean, you can go to any broker and they're gonna say, what's your trading volume? You could have a share price at eight bucks and if it doesn't trade, no one's gonna be interested. Or you could have a stock at five cents and if it trades millions of shares, like you're saying with lots of liquidity, you're gonna be able to do a bot deal financing in 24 hours. It's the liquidity that's more valuable as long as you've got the underlying equity within the business and the value to sustain it. That's what matters is the liquidity, not necessarily the price. And then over time, typically what we see doing this for years, I've seen that over time, good companies always go up. Over time, good companies almost always go up. And we're seeing that in the cannabis sector as a whole now, where we had this huge push in 2017, 2018, like everyone made a killing. Then from 2018 to 2020, we had this happen, especially in Canada. And now it's going back up again. And everyone's getting excited about it again and everyone's throwing money at it again. And you see GW Pharma doing a $7 billion deal. This is a sign of once again, the sector's becoming- And the stock was trading at a billion dollars a year ago. Remember? Just look at that. I know. And then one stock I'd like to point out, and this is one point I haven't covered and I should cover it, is that the dispensaries we're buying from high tide, we'll hopefully have it done in the next month. It's just been a COVID thing with the AGLC. The AGLC has to be the hardest agency I have ever dealt with in terms of, I mean, we get fingerprinted and we get interviewed in every jurisdiction. The AGLC is required, I'm single, but like Louisa's husband's tax returns for three years, so during COVID. So the reason that deal has been delayed is really, the AGLC is in COVID mode, even though it's Alberta, which is let's say in less COVID mode than other places, but that deal's gonna happen. And I think Raj Grover to me is like a brother, right? And the way high tide has performed and the way he's executed is just something to learn from. It's just remarkable, right? I mean, we got a 10X on that stock, right? The meta acquisition and the stock's gone from like 14 cents to a dollar. Our entire community is actually involved in high tide and everyone's been killing. It's been extreme. Have you had Raj on? No, I haven't. Okay, I'm gonna watch after him afterwards and tell him it should come on. I think he's a little bit shy. Like we've talked about high tide. We've worked with high tide. I've never had him on our show because I think he is a little bit shy of the camera a little bit. Right, so let me tell you what I'm thinking. So he has a whole bunch of other dispensaries. He's gonna have to sort of, I think, shed. And then I've been speaking to some guys who operate dispensaries in BC and sort of this thoughts been coming through my head with this. And I think there's an opportunity if we can sort of like, we got California and Oregon and then everyone said, what do you do with these three dispensaries in Canada? Well, to me, Canada next to California is the second largest market in North America, right? Okay, and there's a lot of, how do I put it? There was a lot of money put into Canada. And I'm starting to see now what I call a lot of sort of classic PE plays, right? Like with Raj, he's sort of doing a seller lease back. So he's saying, look, I'll take care of the stores for a while. You guys learn the business and then you guys can start building your own chain and you have Cush Bar, which is a good name. And so I've been thinking to myself, and it's just sort of initial thoughts, we have these great brands. We have Skittles, we have Flower Shop. We have Hush as a value brand. And these brands are starting to get recognition, substantial recognition, right? And if GEZ is pushing Flower Shop, and I mean Skittles is just Skittles. I mean, everyone knows it and follows it. I mean, the nose on that stuff is just amazing. And so now I've been thinking, okay, now let's work with an LP, maybe one or two LPs. Let's get our products listed. We'll have a couple of dispensaries and let's slowly, slowly sort of build our own little Canadian ecosystem, you know, with our products as we get them listed with a smaller LP, right? And slowly like build sort of, you know, our own little quality ecosystem like we're doing in LA, right? I think there's another sort of opportunity, it's in Canada. I agree with you. I mean, people here love their cannabis, let's be honest. Yeah, that's true. They love their cannabis and they love cannabis products. They love cannabis 2.0 products. And I think this is a huge market and I think there was a lot of mistakes made. And like you said, there's a lot of opportunity now because everything was hugely undervalued. It got to the point where it was almost ridiculous when you saw high tide at 14 cents, right? Now you see them a month later at a dollar. Yeah. I mean, they just seven X in like a month. They're not the only one. That's, yeah, there are a few who've done that, but yeah, definitely. And now with this sort of what I call this overhang from the spot feel behind us, I'm feeling good. I'm feeling really comfortable and really confident about where we're at and where we're headed, you know? Good. I mean, we've gone through pretty much all the questions. There's really no questions left from the members. You've pretty much broke everything down. It's been a pretty detailed video. Is there anything else you want to discuss before we say goodbye? Well, not much. I mean, thanks for having me. And, you know, thank you for, you know, supporting us, you know, when we were at three cents, four cents, and, you know, really having the view, you know, we, I put in, you know, you gave me some advice on that preferred shelf. I put in that preferred shelf now. Right. You know, I did everything, you know, like, I mean, you know, you've given some good advice too, Rich. I mean, I, you know, we put in that whole shelf there. We did everything, you know, when you told me to do that. It costed an arm and a leg. It was a real pain, but we did it, you know, and... But now you have an equity instrument that you can utilize to go and acquire your growth. That's right. And that was really smart, you know? And I love, you know, everyone who hits me up on Twitter, shareholders hit me up all the time on, you know, email, and I try to get to everybody. I mean, sometimes I can't. I mean, just while we are sitting here, I'm seeing my emails at 128, seeing my Twitter at, I think they're 20 now, 20 right now. You know, I try to clear it, but, you know, we try to give everyone, try to be as fully transparent as we can and make sure everyone has equal information. I think you've done a great job, Karen. I'm so proud of you guys, and I'm so happy that you guys are turning the corner. And I really believe that this is going to be one of those undervalued, under-appreciated, under-exposed stories. Last time we talked, you talked about NASDAQ. I got really excited about that. At the time, I believe the stock was at five cents. Now we're, you know, double that. So the stock has already doubled since the last time you were on the show. And hopefully each and every time we do this, we'll consistently see some price appreciation that we can talk about. That would be great. That would be great. It would be great. Yeah, yeah. Right now we're at 11. Let's say we're at 11 now. Let's say that next target at 22, you know, where there's a will, there's a way, and just got to keep focused and find it. And you know, that's one of the things that we really take pride in here at Rich TV Live, is we're not just a YouTuber that's just trying to talk about companies. We want to get on the inside and speak with the CEOs and get a chance to do these types of things where you can just kind of like talk about everything that's going on, and then shareholders can really get a chance to see what's going on behind the scenes, behind the symbols, behind the press releases. That's the whole concept behind our platform is we want to be more than just a platform that gives you a pick and a symbol and breaks the news. We want to be able to speak to the CEOs like this and answer the questions and have those tough questions answered. And you've been amazing in the sense that you've really never shied away from answering anything. And I think that that shows why you guys have been able to succeed in a very, very difficult time going through, like you said, the vape crisis, the COVID-19 crisis and the cannabis crash. And you've come out the other side and you're really looking strong. And we talked about this when everyone else was selling, you were buying. When everyone else was going bankrupt or selling off assets to other larger LPs and MSOs, you guys were buyers. You guys were acquiring your growth. You were acquiring assets. And that's a smart way to do it. Acquire growth, buy low, obviously gain assets, gain value, gain market share and build a real business. And it's something I've always said to everyone. I said, despite the share price, Halo has a real business. G-Eazy wouldn't be working with Halo if he didn't believe that they had a real business. And partnerships like that is really what I believe is going to separate you guys from a lot of other companies. Because I think that's a great partnership with a global musician who's known all over the world and has a massive, massive brand. And I really like that move. And I like a lot of the moves you guys have been making. Well, I appreciate it. And thanks for having me on. Hey, always a pleasure. Kiran Sudu, the CEO of Halo Collective, H-A-L-O in Canada, A-G-E-E-F in America. If you guys like this video. Actually, now it's a new symbol in America. It's H-CAN-F. So H as in happy, C as in Charlie, A as in alpha, N as in Nancy, and F for foreign. There we go. So now we have a new symbol in America as well. So always changing, always evolving, always adapting. Thank you so much for joining us. And guys, remember, Rich TV Live is strictly for education and entertainment purposes. Always do your due diligence. Always do your research before you invest in anything that we talk about here in Rich TV Live. Speak to a financial advisor. Get their opinion before you make any investments. If you like the video, smash the like button, comment down below, share the video everywhere, and subscribe. Thank you guys for watching. Kiran, thank you for your time today. Keep up the great work and hope to have you on the show again soon. All right, thanks, Rich. Take care. Thank you, Kiran. Thank you guys for watching. Have a nice day, everybody.